Results 261 to 270 of about 4,689,501 (274)
Some of the next articles are maybe not open access.
Interleukin-1β stimulates galectin-9 expression in human astrocytes
Neuroreport, 2001Galectin-9 is an eosinophil chemoattractant produced by activated T lymphocytes. We have addressed expression of galectin-9 in normal human astrocytes in culture. Expression of galectin-9 mRNA and protein were examined by reverse transcription-polymerase chain reaction (RT-PCR), Western blotting, and immunofluorescent staining.
H, Yoshida +20 more
openaire +2 more sources
Galectin-9 in tumor biology: A jack of multiple trades
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2013Galectin family members have been shown to exert multiple roles in the context of tumor biology. Several recent findings support a similar multi-faceted role for galectin-9. Galectin-9 expression is frequently altered in cancer as compared to normal tissues.
Heusschen, Roy +2 more
openaire +4 more sources
[Serum galectin-9 in cervical cancer].
Zhonghua yi xue za zhi, 2009To investigate the expression level of Galectin-9 (Gal-9) in the serum of cervical cancer patients and analyze the clinic significance of it.Collected sera from 29 patients with cervical cancer, 45 patients with cervical inter-epithelial lesion (CIN) and 26 normal females. Determination of Gal-9 was performed by ELISA, and in the group of patients with
Mei-yan, Liang +3 more
openaire +1 more source
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
Nature Immunology, 2005Chen Zhu +8 more
semanticscholar +1 more source
Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology
With the ongoing advancement of immune checkpoint research, targeting tumors through immune checkpoint blockade has emerged as a crucial approach in cancer therapy. T cell immunoglobulin and mucin-domain containing protein 3 (TIM-3) functions as a negative immune checkpoint.
Lanxin, Ma, Li, Bai
openaire +1 more source
With the ongoing advancement of immune checkpoint research, targeting tumors through immune checkpoint blockade has emerged as a crucial approach in cancer therapy. T cell immunoglobulin and mucin-domain containing protein 3 (TIM-3) functions as a negative immune checkpoint.
Lanxin, Ma, Li, Bai
openaire +1 more source
Abstract B7-H4, a member of the B7 family, is broadly expressed on various cancer cells and has been implicated in negative immune regulation, particularly in suppressing anti-tumor immunity. However, the receptor for B7-H4 and the molecular mechanisms underlying its immunoinhibitory effects remain poorly understood.
Ravear Zhiqiang Wang +2 more
openaire +1 more source
Ravear Zhiqiang Wang +2 more
openaire +1 more source

